Genesis Therapeutics
Alexander Izvorski has a diverse work experience spanning multiple industries. Alexander started their career as a Lead Programmer at the C. Everett Koop Institute in 1996 and then moved on to become the Chief Technical Officer at News Patterns from 2000 to 2004. Alexander then joined Avail-TVN as the Director of Software Engineering from 2005 to 2009. In 2010, they founded Fountain Bioscience and served as its President till 2012. Alexander then held various roles such as Software Architect at BitGravity, Principal Engineer at CiiNOW, and Head of Data Sciences at Mousera from 2012 to 2014. From 2014 to 2019, they worked as the Chief Scientific Officer at Enso Relief. In 2019, they became the Chief Data Scientist at SocialEyes Corporation and eventually moved to Genesis Therapeutics in 2020 as a Research Scientist.
Alexander Izvorski attended Dartmouth College from 1993 to 1997, where they earned a Bachelor's Degree in Biochemistry and Molecular Biology/Mathematics.
This person is not in the org chart
Genesis Therapeutics
3 followers
Genesis Therapeutics is an innovative biotechnology company engaging its proprietary molecular AI technology to transform clinical outcomes for patients. The company was founded in 2019 out of Stanford University by Evan Feinberg Ph.D., co-founded by Ben Sklaroff, and backed by Vijay Pande, Ph.D. In addition, Peppi Prasit, Ph.D. leads the Scientific Advisory Board and Leonard Bell, M.D., serves as Chair of the Board of Directors. Its team of technology trailblazers and proven drug developers are driving the discovery and development of novel small molecule drugs to treat patients suffering with severe and debilitating diseases. The company expects to develop drug candidates both internally and selectively in partnership with biopharmaceutical companies.